Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
Katiuscia Pagano, Simona Tomaselli, Henriette Molinari, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien‐Yuan Lane, Chieh‐Hsin Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8208-8208
Open Access | Times Cited: 128
Polyphenols and neuroprotection: Therapeutic implications for cognitive decline
Giuseppe Caruso, Sebastiano Alfio Torrisi, Maria P. Mogavero, et al.
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108013-108013
Closed Access | Times Cited: 100
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 74
Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review
Jinjin Pei, Chella Perumal Palanisamy, Prabhu Manickam Natarajan, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102393-102393
Closed Access | Times Cited: 10
Polycatechols inhibit ferroptosis and modulate tau liquid–liquid phase separation to mitigate Alzheimer's disease
Hariharan Moorthy, Madhu Ramesh, Dikshaa Padhi, et al.
Materials Horizons (2024) Vol. 11, Iss. 13, pp. 3082-3089
Closed Access | Times Cited: 9
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation
Bingkuan Xu, Jing Chen, Yinghui Liu
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30281-30290
Open Access | Times Cited: 37
Myricetin Inhibits α‐Synuclein Amyloid Aggregation by Delaying the Liquid‐to‐Solid Phase Transition
Bingkuan Xu, Xiaoli Mo, Jing Chen, et al.
ChemBioChem (2022) Vol. 23, Iss. 16
Closed Access | Times Cited: 28
Inhibition of toxic metal-alpha synuclein interactions by human serum albumin
Karla Martinez Pomier, Rashik Ahmed, Jinfeng Huang, et al.
Chemical Science (2024) Vol. 15, Iss. 10, pp. 3502-3515
Open Access | Times Cited: 7
Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide
Sara La Manna, Marilisa Leone, Ilaria Iacobucci, et al.
Inorganic Chemistry (2022) Vol. 61, Iss. 8, pp. 3540-3552
Open Access | Times Cited: 27
The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
Nobumasa Takasugi, Masato Komai, Nanaka Kaneshiro, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 454-454
Open Access | Times Cited: 15
A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action
Sara La Manna, Concetta Di Natale, Valeria Panzetta, et al.
Inorganic Chemistry (2023) Vol. 63, Iss. 1, pp. 564-575
Open Access | Times Cited: 14
Reactive oxygen species may cause amyloid beta aggregation by free radical polymerization
Abdul Majid, Sanjeev Garg
Journal of Applied Polymer Science (2024) Vol. 141, Iss. 14
Closed Access | Times Cited: 5
Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases
Araz Rahimi, Parsa Sameei, Sana Mousavi, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9416-9431
Closed Access | Times Cited: 5
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
Nikita Navolokin, Viktoria Adushkina, Daria Zlatogorskaya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 788-788
Open Access | Times Cited: 5
Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
Jiarui Wu, Xiaodi Kou, Hui Ju, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128316-128316
Closed Access | Times Cited: 32
The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer’s Disease In Vitro
Barbara Mavroidi, Archontia Kaminari, Dimitris Matiadis, et al.
Brain Sciences (2022) Vol. 12, Iss. 6, pp. 806-806
Open Access | Times Cited: 19
Therapeutic Candidates for Alzheimer’s Disease: Saponins
Ruifeng Zhang, Miao Zeng, Xiaolu Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10505-10505
Open Access | Times Cited: 11
Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model
Wen-Han Chuang, Yu‐Ting Chou, Yihong Chen, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 16, pp. 2922-2934
Closed Access | Times Cited: 11
Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116684-116684
Closed Access | Times Cited: 4
Nanoparticle-Mediated Therapy for Alzheimer’s Disease
Arumugam Vijayan, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Nanotechnology in the life sciences (2025), pp. 203-223
Closed Access
Inhibition of amyloid formation of prion fragment (106–128) by polyphenolic compounds
Deepika Regmi, S. K. L. Haque, Md Raza Ul Karim, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025) Vol. 1869, Iss. 5, pp. 130778-130778
Closed Access
Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part A: Endogenous Compounds and Repurposed Drugs
Mariyana Atanasova
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 306-306
Open Access
A Brain-Penetrating Foldamer Rescues Aβ Aggregation-Associated Alzheimer’s Disease Phenotypes in In Vivo Models
Charles Zuwu Baysah, Ryan A. Dohoney, L. Palanikumar, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Multifunctional Metal–Organic Framework as a Versatile Nanoplatform for Aβ Oligomer Imaging and Chemo-Photothermal Treatment in Living Cells
Xueyan Yan, Yixin Pan, Liang Ji, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 41, pp. 13823-13834
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top